NDC 59088-747

GABAPAL

Gabapentin, Lidocaine Hydrochloride

GABAPAL is a Oral; Topical Kit in the Human Prescription Drug category. It is labeled and distributed by Puretek Corporation. The primary component is .

Product ID59088-747_9cfd2461-a093-7f17-e053-2a95a90abbd3
NDC59088-747
Product TypeHuman Prescription Drug
Proprietary NameGABAPAL
Generic NameGabapentin, Lidocaine Hydrochloride
Dosage FormKit
Route of AdministrationORAL; TOPICAL
Marketing Start Date2020-01-25
Marketing CategoryANDA / ANDA
Application NumberANDA204989
Labeler NamePureTek Corporation
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 59088-747-00

1 KIT in 1 CARTON (59088-747-00) * 24 CAPSULE in 1 BOTTLE * 1 TUBE in 1 CARTON (59088-371-07) > 85 g in 1 TUBE
Marketing Start Date2020-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59088-747-00 [59088074700]

GABAPAL KIT
Marketing CategoryANDA
Application NumberANDA204989
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-01

Drug Details

OpenFDA Data

SPL SET ID:9cfd2461-a092-7f17-e053-2a95a90abbd3
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1723996
  • 310430
  • 1723991
  • NDC Crossover Matching brand name "GABAPAL" or generic name "Gabapentin, Lidocaine Hydrochloride"

    NDCBrand NameGeneric Name
    59088-747GABAPALGABAPENTIN, LIDOCAINE HYDROCHLORIDE
    59088-736GPL PakGABAPENTIN, LIDOCAINE HYDROCHLORIDE
    59088-743Lido GB-300GABAPENTIN, LIDOCAINE HYDROCHLORIDE
    59088-749LidotinGABAPENTIN, LIDOCAINE HYDROCHLORIDE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.